Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
US Army
US Department of Justice
Merck
Fish and Richardson
Boehringer Ingelheim
Mallinckrodt
Dow
Federal Trade Commission

Generated: May 24, 2018

DrugPatentWatch Database Preview

FLEXERIL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Flexeril, and what generic alternatives are available?

Flexeril is a drug marketed by Janssen Res And Dev and is included in one NDA.

The generic ingredient in FLEXERIL is cyclobenzaprine hydrochloride. There are fifteen drug master file entries for this compound. Eighty-two suppliers are listed for this compound. Additional details are available on the cyclobenzaprine hydrochloride profile page.
Summary for FLEXERIL
Drug patent expirations by year for FLEXERIL
Synonyms for FLEXERIL
(3-Dibenzo[a,d]cyclohepten-5-ylidene-propyl)-dimethyl-amine
0VE05JYS2P
1-Propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-
1-Propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride
1-Propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-(9CI)
1-Propanamine, 3-(5H-dibenzo[a,d]cyclohepten- 5-ylidene)-N,N-dimethyl-, hydrochloride
1-Propanamine, 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-
1-Propanamine,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride
10,11-Dehydroamitriptyline
10,11.delta.-Amitriptyline hydrochloride
10,11delta-Amitriptyline hydrochloride
202C239
3-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)propyl(dimethyl)ammonium chloride
3-(5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine
3-(5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine hydrochloride
3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine
3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine #
3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine Hydrochloride
3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine
3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine hydrochloride
3-(dibenzo[[?],[?]][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine
3-(dibenzo[1,2-a:1',2'-e][7]annulen-11-ylidene)-N,N-dimethylpropan-1-amine
3-(dibenzo[2,1-b:1',2'-e][7]annulen-11-ylidene)-N,N-dimethylpropan-1-amine;hydrochloride
303-53-7
303-53-7 (Parent)
303C537
5-(3-dimethylaminopropylidene)- 5H-dibenzo[a,d]cycloheptene
5-(3-Dimethylaminopropylidene)-5H-dibenzo-(a,d)cycloheptene hydrochloride
5-(3-dimethylaminopropylidene)-5H-dibenzo[a,d]cycloheptene
5-(3-Dimethylaminopropylidene)dibenzo[a,e]cycloheptatriene hydrochloride
5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene
5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene [Italian]
5-[3-(Dimethylamino)propylidene]-5H-dibenzo-[a,d]cycloheptene hydrochloride
5H-Dibenzo(a,d)cycloheptene-.delta.5,.gamma.-propylamine, N,N-dimethyl-
5H-Dibenzo(a,d)cycloheptene-delta(sup 5)-gamma-propylamine, N,N-dimethyl-, hydrochloride
5H-DIBENZO(a,d)CYCLOHEPTENE-delta(sup 5),gamma-PROPYLAMINE, N,N-DIMETHYL-
5H-Dibenzo(a,d)cycloheptene-delta5,gamma-propylamine, N,N-dimethyl-, hydrochloride
5H-Dibenzo(a,d)cycloheptene-delta5,gamma-propylamine, N,N-dimethyl-, hydrochloride (8CI)
5H-Dibenzo[a, N,N-dimethyl-, hydrochloride
5H-Dibenzo[a,.gamma.-propylamine, N,N-dimethyl-, hydrochloride
6202-23-9
6202-23-9 (hydrochloride)
69O5WQQ5TI
9715 R.P
9715 R.P.
AB00053651_07
AB00514668
AC-1916
AC1L1EPQ
AC1L2KN5
ACT06294
AJ-24590
AK115687
AKOS015906329
AKOS025255657
Amrix
Amrix (Salt/Mix)
Amrix (TN)
AN-14454
AN-44194
Apo-Cyclobenzaprine (TN)
AS-15745
BBL035415
BCP9000565
BDBM112774
BIDD:GT0485
BIDD:PXR0152
BPBio1_000540
BRD-K42348709-003-05-7
BSPBio_000490
BSPBio_003072
C 4542
C-17361
C-19294
C06931
C20H21N.HCl
CAS-6202-23-9
CC-26026
CC-26027
CCG-36511
CCG-39312
CHEBI:3996
CHEBI:3997
CHEMBL1200636
CHEMBL669
Ciclobenzaprina
Ciclobenzaprina [INN-Spanish]
Cloben
CS-2981
CTK8F8847
Cyben
Cyclobenz
cyclobenzaprine
Cyclobenzaprine (hydrochloride)
Cyclobenzaprine (INN)
Cyclobenzaprine [INN]
Cyclobenzaprine HCL
Cyclobenzaprine hydrochloride
Cyclobenzaprine hydrochloride (Salt/Mix)
Cyclobenzaprine hydrochloride (USP)
Cyclobenzaprine hydrochloride [USAN:USP]
Cyclobenzaprine hydrochloride [USAN]
Cyclobenzaprine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Cyclobenzaprine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Cyclobenzaprine very low dose
CYCLOBENZAPRINEHCL
Cyclobenzaprinum
Cyclobenzaprinum [INN-Latin]
Cycloflex
Cycloflex (Salt/Mix)
D00772
D01KHH
D07758
D0NN8N
DB00924
dimethyl({3-[(2E)-tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene]propyl})amine
dimethyl({3-[(2E)-tricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene]propyl})amine
DIMETHYL(3-{TRICYCLO[9.4.0.0(3),?]PENTADECA-1(15),3,5,7,9,11,13-HEPTAEN-2-YLIDENE}PROPYL)AMINE HYDROCHLORIDE
DivK1c_000047
DR001318
DSSTox_CID_25105
DSSTox_GSID_45105
DSSTox_RID_80672
DTXSID0046933
DTXSID2045105
E yenCaIaeAO
EINECS 206-145-8
EINECS 228-264-4
EU-0100303
EUR-1002
Fexmid
Fexmid(TN)
Flexeril (Salt/Mix)
Flexeril (TN)
Flexeril hydrochloride
Flexiban
FT-0603166
FT-0603167
GTPL7152
HMS1569I12
HMS1922I11
HSDB 8305
HY-B0740
IDI1_000047
JURKNVYFZMSNLP-UHFFFAOYSA-N
KB-76226
KBio1_000047
KBio2_002015
KBio2_004583
KBio2_007151
KBio3_002572
KBioGR_000643
KBioSS_002015
L001021
Lisseril
Lopac-C-4542
Lopac0_000303
LP00303
LS-60766
LS-60768
M-1230
MFCD00079039
Miosan
MK 130
MK 130 hydrochloride
MK-130
MK-130 [AS THE BASE]
MK-130 HCl
MLS002153815
MolPort-003-666-812
MolPort-006-111-174
MRF-0000742
Multi-Relax
N,d]cycloheptene-.delta.,5.gamma.-propylamine, hydrochloride
N,d]cycloheptene-.delta.(sup5,.gamma.)-propylamine hydrochloride
N,N-Dimethyl-3-(dibenzo(a,d)cycloheptene-4-ylidene)propylamine
N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-.delta.5,.gamma.-propylamine
N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-Delta(5,gamma)-propylamine
N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-Delta(5,gamma)-propylamine hydrochloride
N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5,gamma)-propylamine hydrochloride
N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine
N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta5,gamma-propylamine
NCGC00013841
NCGC00013841-01
NCGC00013841-02
NCGC00013841-03
NCGC00013841-04
NCGC00013841-05
NCGC00013841-06
NCGC00013841-08
NCGC00013841-09
NCGC00093752-01
NCGC00093752-02
NCGC00093752-03
NCGC00093752-04
NCGC00093752-05
NCGC00095017-01
NCGC00095017-02
NCGC00095017-03
NCGC00095017-04
NCGC00096951-01
NCGC00162122-01
NCGC00260988-01
NCI60_041725
NCI78206
NCIStruc1_001572
NCIStruc2_001486
NINDS_000047
Novo-Cycloprine
NSC 169900
NSC 173379
NSC 78206
NSC-169900
NSC-173379
NSC-758414
NSC-78206
NSC169900
NSC173379
NSC758414
NSC78206
Oprea1_534683
Pharmakon1600-01503207
PL053563
Prestwick_790
Prestwick0_000445
Prestwick1_000445
Prestwick2_000445
Prestwick3_000445
Proeptatriene
Proeptatriene [Italian]
Proheptatrien
Proheptatrien monohydrochloride
Proheptatriene
Proheptatriene hydrochloride
Proheptatriene monohydrochloride
PubChem15660
PubChem18912
Q517
QTL1_000027
Ro 4-1577
RP 9715
s4283
SBI-0050291.P003
SC-18388
SCHEMBL38527
SCHEMBL41376
SMR000326702
SPBio_001348
SPBio_002429
Spectrum_001535
SPECTRUM1503207
Spectrum2_001534
Spectrum3_001566
Spectrum4_000162
Spectrum5_001259
SR-01000075761
SR-01000075761-1
ST24041508
ST51054170
STL416209
Tabradol
Tensodox
TNX-102
TNX-102 SL
TNX-105
Tonmya
Tox21_110040
Tox21_110040_1
Tox21_500303
UNII-0VE05JYS2P
UNII-69O5WQQ5TI
US8629135, SW-01
VXEAYBOGHINOKW-UHFFFAOYSA-N
W-105056
WLN: L C676 BHJ B3N1&1 &GH
Yurelax
ZINC968263

US Patents and Regulatory Information for FLEXERIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Res And Dev FLEXERIL cyclobenzaprine hydrochloride TABLET;ORAL 017821-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Res And Dev FLEXERIL cyclobenzaprine hydrochloride TABLET;ORAL 017821-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for FLEXERIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Res And Dev FLEXERIL cyclobenzaprine hydrochloride TABLET;ORAL 017821-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Janssen Res And Dev FLEXERIL cyclobenzaprine hydrochloride TABLET;ORAL 017821-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Janssen Res And Dev FLEXERIL cyclobenzaprine hydrochloride TABLET;ORAL 017821-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Janssen Res And Dev FLEXERIL cyclobenzaprine hydrochloride TABLET;ORAL 017821-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKinsey
Chubb
Fuji
Healthtrust
Merck
Teva
QuintilesIMS
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.